Shenzhen Chipscreen Biosciences(688321.SH): Xioroni capsules granted approval for drug clinical trials.

15:58 08/01/2026

Wison Biotechnology (688321.SH) announced that the company has recently received the "Notice of Approval for Clinical Trial of Drugs" issued by the National Medical Products Administration, which approved the company's product Xelione Capsules to carry out clinical research on the first-line treatment of metastatic pancreatic ductal adenocarcinoma in combination with Trepilumab and chemotherapy.

Shenzhen Chipscreen Biosciences (688321.SH) announced that the company has recently received a "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, authorizing the company to conduct a clinical study on the combination of its product Xioloni capsules with Trepulimab and first-line chemotherapy for the treatment of metastatic pancreatic ductal adenocarcinoma.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"